ID   PKD1_HUMAN              Reviewed;        4303 AA.
AC   P98161; Q15140; Q15141;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   23-MAR-2010, sequence version 3.
DT   16-MAR-2016, entry version 200.
DE   RecName: Full=Polycystin-1;
DE   AltName: Full=Autosomal dominant polycystic kidney disease 1 protein;
DE   Flags: Precursor;
GN   Name=PKD1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT THR-1092.
RX   PubMed=7736581;
RA   Gluecksmann-Kuis M.A., Tayber O., Woolf E.A., Bougueleret L., Deng N.,
RA   Alperin G.D., Iris F., Hawkins F., Munro C., Lakey N., Duyk G.,
RA   Schneider M.C., Geng L., Zhang F., Zhao Z., Torosian S., Reeders S.T.,
RA   Bork P., Pohlschmidt M., Loehning C., Kraus B., Nowicka U.,
RA   Leung A.L.S., Frischauf A.-M.;
RT   "Polycystic kidney disease: the complete structure of the PKD1 gene
RT   and its protein.";
RL   Cell 81:289-298(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 2 AND 3), AND
RP   VARIANT GLN-739.
RX   PubMed=7663510; DOI=10.1038/ng0695-151;
RA   Hughes J., Ward C.J., Peral B., Aspinwall R., Clark K.,
RA   San Millan J.L., Gamble V., Harris P.C.;
RT   "The polycystic kidney disease 1 (PKD1) gene encodes a novel protein
RT   with multiple cell recognition domains.";
RL   Nat. Genet. 10:151-160(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X.,
RA   Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A.,
RA   Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J.,
RA   Buckingham J.M., Callen D.F., Campbell C.S., Campbell M.L.,
RA   Campbell E.W., Caoile C., Challacombe J.F., Chasteen L.A.,
RA   Chertkov O., Chi H.C., Christensen M., Clark L.M., Cohn J.D.,
RA   Denys M., Detter J.C., Dickson M., Dimitrijevic-Bussod M., Escobar J.,
RA   Fawcett J.J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Goodwin L.A., Grady D.L., Grigoriev I.,
RA   Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E., Huang W.,
RA   Israni S., Jett J., Jewett P.B., Kadner K., Kimball H., Kobayashi A.,
RA   Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y., Lowry S.,
RA   Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L.,
RA   Rash S., Retterer J., Ricke D.O., Robinson D.L., Rodriguez A.,
RA   Salamov A., Saunders E.H., Scott D., Shough T., Stallings R.L.,
RA   Stalvey M., Sutherland R.D., Tapia R., Tesmer J.G., Thayer N.,
RA   Thompson L.S., Tice H., Torney D.C., Tran-Gyamfi M., Tsai M.,
RA   Ulanovsky L.E., Ustaszewska A., Vo N., White P.S., Williams A.L.,
RA   Wills P.L., Wu J.-R., Wu K., Yang J., DeJong P., Bruce D.,
RA   Doggett N.A., Deaven L., Schmutz J., Grimwood J., Richardson P.,
RA   Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M., Myers R.M.,
RA   Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] OF 2769-4303.
RX   PubMed=8004675;
RA   Ward C.J., Peral B., Hughes J., Thomas S., Gamble V., Maccarthy A.B.,
RA   Sloane-Stanley J., Buckle V.J., Kearney L., Higgs D.R.,
RA   Ratcliffe P.J., Harris P.C., Roelfsema J.H., Spruit L.L., Saris J.J.,
RA   Dauwerse H.G., Peters D.J.M., Breuning M.H., Nellist M.,
RA   Brook-Carter P.T., Maheshwar M.M., Cordeiro I., Santos H., Cabral P.,
RA   Sampson J.R., Janssen B., Hesseling-Janssen A.L.W.,
RA   van den Ouweland A.M.W., Eussen B., Verhoef S., Lindhout D.,
RA   Halley D.J.J.;
RT   "The polycystic kidney disease 1 gene encodes a 14 kb transcript and
RT   lies within a duplicated region on chromosome 16.";
RL   Cell 77:881-894(1994).
RN   [5]
RP   ERRATUM.
RX   PubMed=8069919;
RA   Ward C.J., Peral B., Hughes J., Thomas S., Gamble V., Maccarthy A.B.,
RA   Sloane-Stanley J., Buckle V.J., Kearney L., Higgs D.R.,
RA   Ratcliffe P.J., Harris P.C., Roelfsema J.H., Spruit L.L., Saris J.J.,
RA   Dauwerse H.G., Peters D.J.M., Breuning M.H., Nellist M.,
RA   Brook-Carter P.T., Maheshwar M.M., Cordeiro I., Santos H., Cabral P.,
RA   Sampson J.R., Janssen B., Hesseling-Janssen A.L.W.,
RA   van den Ouweland A.M.W., Eussen B., Verhoef S., Lindhout D.,
RA   Halley D.J.J.;
RL   Cell 78:725-725(1994).
RN   [6]
RP   INTERACTION WITH RGS7, AND SUBCELLULAR LOCATION.
RX   PubMed=10339594; DOI=10.1073/pnas.96.11.6371;
RA   Kim E., Arnould T., Sellin L., Benzing T., Comella N., Kocher O.,
RA   Tsiokas L., Sukhatme V.P., Walz G.;
RT   "Interaction between RGS7 and polycystin.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:6371-6376(1999).
RN   [7]
RP   FUNCTION IN RENAL TUBULOGENESIS, CLEAVAGE AT GPS DOMAIN,
RP   CHARACTERIZATION OF VARIANTS PKD1 LYS-2771; PRO-2921; PRO-2993 AND
RP   ARG-3016, AND CHARACTERIZATION OF VARIANT GLN-2791.
RX   PubMed=12482949; DOI=10.1073/pnas.252484899;
RA   Qian F., Boletta A., Bhunia A.K., Xu H., Liu L., Ahrabi A.K.,
RA   Watnick T.J., Zhou F., Germino G.G.;
RT   "Cleavage of polycystin-1 requires the receptor for egg jelly domain
RT   and is disrupted by human autosomal-dominant polycystic kidney disease
RT   1-associated mutations.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:16981-16986(2002).
RN   [8]
RP   AUTOPROTEOLYTIC CLEAVAGE, DETERMINATION OF AUTOPROTEOLYTIC CLEAVAGE
RP   SITE, AND MUTAGENESIS OF THR-3049.
RX   PubMed=17525154; DOI=10.1074/jbc.M703218200;
RA   Wei W., Hackmann K., Xu H., Germino G., Qian F.;
RT   "Characterization of cis-autoproteolysis of polycystin-1, the product
RT   of human polycystic kidney disease 1 gene.";
RL   J. Biol. Chem. 282:21729-21737(2007).
RN   [9]
RP   PHOSPHORYLATION AT SER-4166, AND INTERACTION WITH PRKX.
RX   PubMed=17980165; DOI=10.1016/j.bbadis.2007.09.003;
RA   Li X., Burrow C.R., Polgar K., Hyink D.P., Gusella G.L., Wilson P.D.;
RT   "Protein kinase X (PRKX) can rescue the effects of polycystic kidney
RT   disease-1 gene (PKD1) deficiency.";
RL   Biochim. Biophys. Acta 1782:1-9(2008).
RN   [10]
RP   SUBCELLULAR LOCATION.
RX   PubMed=20980620; DOI=10.1091/mbc.E10-05-0407;
RA   Chapin H.C., Rajendran V., Caplan M.J.;
RT   "Polycystin-1 surface localization is stimulated by polycystin-2 and
RT   cleavage at the G protein-coupled receptor proteolytic site.";
RL   Mol. Biol. Cell 21:4338-4348(2010).
RN   [11]
RP   INTERACTION WITH NPHP1.
RX   PubMed=20856870; DOI=10.1371/journal.pone.0012719;
RA   Wodarczyk C., Distefano G., Rowe I., Gaetani M., Bricoli B.,
RA   Muorah M., Spitaleri A., Mannella V., Ricchiuto P., Pema M.,
RA   Castelli M., Casanova A.E., Mollica L., Banzi M., Boca M.,
RA   Antignac C., Saunier S., Musco G., Boletta A.;
RT   "Nephrocystin-1 forms a complex with polycystin-1 via a polyproline
RT   motif/SH3 domain interaction and regulates the apoptotic response in
RT   mammals.";
RL   PLoS ONE 5:E12719-E12719(2010).
RN   [12]
RP   INTERACTION WITH BBS1; BBS4; BBS5 AND TTC8.
RX   PubMed=24939912; DOI=10.1093/hmg/ddu267;
RA   Su X., Driscoll K., Yao G., Raed A., Wu M., Beales P.L., Zhou J.;
RT   "Bardet-Biedl syndrome proteins 1 and 3 regulate the ciliary
RT   trafficking of polycystic kidney disease 1 protein.";
RL   Hum. Mol. Genet. 23:5441-5451(2014).
RN   [13]
RP   STRUCTURE BY NMR OF 275-354.
RX   PubMed=9889186; DOI=10.1093/emboj/18.2.297;
RA   Bycroft M., Bateman A., Clarke J., Hamill S.J., Sandford R.,
RA   Thomas R.L., Chothia C.;
RT   "The structure of a PKD domain from polycystin-1: implications for
RT   polycystic kidney disease.";
RL   EMBO J. 18:297-305(1999).
RN   [14]
RP   REVIEW.
RX   PubMed=11698076; DOI=10.1016/S0165-6147(00)01832-0;
RA   Stayner C., Zhou J.;
RT   "Polycystin channels and kidney disease.";
RL   Trends Pharmacol. Sci. 22:543-546(2001).
RN   [15]
RP   VARIANT PKD1 3748-ARG--VAL-3752 DEL, AND VARIANT ASP-3632.
RX   PubMed=8554072;
RA   Peral B., San Millan J.L., Ong A.C.M., Gamble V., Ward C.J.,
RA   Strong C., Harris P.C.;
RT   "Screening the 3' region of the polycystic kidney disease 1 (PKD1)
RT   gene reveals six novel mutations.";
RL   Am. J. Hum. Genet. 58:86-96(1996).
RN   [16]
RP   VARIANTS PKD1 PRO-2993; ARG-3016 AND VAL-3511, AND VARIANTS MET-3510
RP   AND PHE-4190.
RX   PubMed=9199561; DOI=10.1086/515467;
RA   Peral B., Gamble V., Strong C., Ong A.C.M., Sloane-Stanley J.,
RA   Zerres K., Winearls C.G., Harris P.C.;
RT   "Identification of mutations in the duplicated region of the
RT   polycystic kidney disease 1 gene (PKD1) by a novel approach.";
RL   Am. J. Hum. Genet. 60:1399-1410(1997).
RN   [17]
RP   VARIANT ALA-4058.
RX   PubMed=9150733; DOI=10.1007/s004390050421;
RA   Constantinides R., Xenophontos S.L., Neophytou P., Nomura S.,
RA   Pierides A., Constantinou-Deltas C.D.;
RT   "New amino acid polymorphism, Ala/Val4058, in exon 45 of the
RT   polycystic kidney disease 1 gene: evolution of alleles.";
RL   Hum. Genet. 99:644-647(1997).
RN   [18]
RP   VARIANTS PKD1 VAL-2763; THR-2826 AND LEU-3008, AND VARIANTS THR-2760;
RP   PRO-2761; THR-2764; GLN-2791 AND LEU-3066.
RX   PubMed=9285784; DOI=10.1093/hmg/6.9.1473;
RA   Watnick T.J., Piontek K.B., Cordal T.M., Weber H., Gandolph M.A.,
RA   Qian F., Lens X.M., Neumann H.P.H., Germino G.G.;
RT   "An unusual pattern of mutation in the duplicated portion of PKD1 is
RT   revealed by use of a novel strategy for mutation detection.";
RL   Hum. Mol. Genet. 6:1473-1481(1997).
RN   [19]
RP   VARIANT PKD1 THR-3678.
RX   PubMed=9259200;
RX   DOI=10.1002/(SICI)1098-1004(1997)10:2<164::AID-HUMU9>3.0.CO;2-K;
RA   Turco A.E., Rossetti S., Bresin E., Englisch S., Corra S.,
RA   Pignatti P.F.;
RT   "Three novel mutations of the PKD1 gene in Italian families with
RT   autosomal dominant polycystic kidney disease.";
RL   Hum. Mutat. 10:164-167(1997).
RN   [20]
RP   VARIANT PKD1 ASP-4032, AND VARIANT VAL-4045.
RX   PubMed=9521593; DOI=10.1007/s004390050681;
RA   Daniells C., Maheshwar M.M., Lazarou L., Davies F., Coles G.,
RA   Ravine D.;
RT   "Novel and recurrent mutations in the PKD1 (polycystic kidney disease)
RT   gene.";
RL   Hum. Genet. 102:216-220(1998).
RN   [21]
RP   VARIANT PKD1 MET-3375.
RX   PubMed=9921908; DOI=10.1007/s004390050896;
RA   Koptides M., Constantinides R., Kyriakides G., Hadjigavriel M.,
RA   Patsalis P.C., Pierides A., Deltas C.C.;
RT   "Loss of heterozygosity in polycystic kidney disease with a missense
RT   mutation in the repeated region of PKD1.";
RL   Hum. Genet. 103:709-717(1998).
RN   [22]
RP   VARIANTS PKD1 LEU-324 AND SER-845, AND VARIANTS ARG-1399 AND LEU-1786.
RX   PubMed=10364515; DOI=10.1086/302460;
RA   Thomas R.L., McConnell R., Whittacker J., Kirkpatrick P., Bradley J.,
RA   Sandford R.;
RT   "Identification of mutations in the repeated part of the autosomal
RT   dominant polycystic kidney disease type 1 gene, PKD1, by long-range
RT   PCR.";
RL   Am. J. Hum. Genet. 65:39-49(1999).
RN   [23]
RP   VARIANTS PKD1 PRO-2392 AND PHE-2423, AND VARIANTS ARG-1399; GLN-2548
RP   AND ARG-2638.
RX   PubMed=10577909; DOI=10.1086/302657;
RA   Watnick T., Phakdeekitcharoen B., Johnson A., Gandolph M.A., Wang M.,
RA   Briefel G., Klinger K.W., Kimberling W., Gabow P., Germino G.G.;
RT   "Mutation detection of PKD1 identifies a novel mutation common to
RT   three families with aneurysms and/or very-early-onset disease.";
RL   Am. J. Hum. Genet. 65:1561-1571(1999).
RN   [24]
RP   VARIANTS PKD1 LEU-LEU-PHE-3996 INS; GLY-4136 AND CYS-4154, AND
RP   VARIANTS.
RX   PubMed=10987650; DOI=10.1007/s004390051094;
RA   Perrichot R.A., Mercier B., Simon P.M., Whebe B., Cledes J., Ferec C.;
RT   "DGGE screening of PKD1 gene reveals novel mutations in a large cohort
RT   of 146 unrelated patients.";
RL   Hum. Genet. 105:231-239(1999).
RN   [25]
RP   VARIANTS PKD1 3748-ARG--VAL-3752 DEL AND LEU-4132 DEL, AND VARIANT
RP   VAL-4045.
RX   PubMed=10647901; DOI=10.1007/s004399900177;
RA   Afzal A.R., Hand M., Ternes-Pereira E., Saggar-Malik A., Taylor R.,
RA   Jeffery S.;
RT   "Novel mutations in the 3 region of the polycystic kidney disease 1
RT   (PKD1) gene.";
RL   Hum. Genet. 105:648-653(1999).
RN   [26]
RP   VARIANTS PKD1 PRO-4225 AND TRP-4276.
RX   PubMed=10200984; DOI=10.1046/j.1523-1755.1999.00368.x;
RA   Badenas C., Torra R., San Millan J.L., Lucero L., Mila M.,
RA   Estivill X., Darnell A.;
RT   "Mutational analysis within the 3' region of the PKD1 gene.";
RL   Kidney Int. 55:1225-1233(1999).
RN   [27]
RP   VARIANTS PKD1 MET-2250; TRP-2329 AND CYS-2379, AND VARIANTS LEU-3066;
RP   VAL-3139 AND LEU-3193.
RX   PubMed=10854095; DOI=10.1038/sj.ejhg.5200459;
RA   Perrichot R., Mercier B., Quere I., Carre A., Simon P., Whebe B.,
RA   Cledes J., Ferec C.;
RT   "Novel mutations in the duplicated region of PKD1 gene.";
RL   Eur. J. Hum. Genet. 8:353-359(2000).
RN   [28]
RP   VARIANTS PKD1 HIS-3247 AND MET-3382.
RX   PubMed=11216660; DOI=10.1089/109065700750065108;
RA   Afzal A.R., Florencio R.N., Taylor R., Patton M.A., Saggar-Malik A.,
RA   Jeffery S.;
RT   "Novel mutations in the duplicated region of the polycystic kidney
RT   disease 1 (PKD1) gene provides supporting evidence for gene
RT   conversion.";
RL   Genet. Test. 4:365-370(2000).
RN   [29]
RP   VARIANTS PKD1 PRO-2921 AND MET-3375, AND VARIANT LEU-3066.
RX   PubMed=10923040;
RX   DOI=10.1002/1098-1004(200008)16:2<176::AID-HUMU11>3.0.CO;2-H;
RA   Koptides M., Mean R., Demetriou K., Constantinides R., Pierides A.,
RA   Harris P.C., Deltas C.C.;
RT   "Screening of the PKD1 duplicated region reveals multiple single
RT   nucleotide polymorphisms and a de novo mutation in Hellenic polycystic
RT   kidney disease families.";
RL   Hum. Mutat. 16:176-176(2000).
RN   [30]
RP   VARIANTS PKD1 GLN-3719 AND PRO-3852, AND VARIANT VAL-4045.
RX   PubMed=11058904;
RX   DOI=10.1002/1098-1004(200011)16:5<444::AID-HUMU11>3.0.CO;2-C;
RA   Aguiari G., Savelli S., Garbo M., Bozza A., Augello G., Penolazzi L.,
RA   De Paoli Vitali E., La Torre C., Cappelli G., Piva R., del Senno L.;
RT   "Novel splicing and missense mutations in autosomal dominant
RT   polycystic kidney disease 1 (PKD1) gene: expression of mutated
RT   genes.";
RL   Hum. Mutat. 16:444-445(2000).
RN   [31]
RP   VARIANTS PKD1 SER-1166; GLU-1956; CYS-2408 AND GLY-2442--2443 INS, AND
RP   VARIANTS HIS-1995 AND ASN-2604.
RX   PubMed=11012875; DOI=10.1046/j.1523-1755.2000.00302.x;
RA   Phakdeekitcharoen B., Watnick T.J., Ahn C., Whang D.-Y., Burkhart B.,
RA   Germino G.G.;
RT   "Thirteen novel mutations of the replicated region of PKD1 in an Asian
RT   population.";
RL   Kidney Int. 58:1400-1412(2000).
RN   [32]
RP   VARIANTS PKD1 TRP-3753 AND ASN-3815.
RX   PubMed=10729710; DOI=10.1016/S1383-5726(99)00013-8;
RA   Kim U.K., Jin D.K., Ahn C., Shin J.H., Lee K.B., Kim S.H., Chae J.J.,
RA   Hwang D.Y., Lee J.G., Namkoong Y., Lee C.C.;
RT   "Novel mutations of the PKD1 gene in Korean patients with autosomal
RT   dominant polycystic kidney disease.";
RL   Mutat. Res. 432:39-45(2000).
RN   [33]
RP   VARIANTS PKD1 GLN-13; PHE-75; CYS-139; 1992-PHE-THR-1993 DELINS LEU;
RP   2220-ARG--PRO-2224 DEL; ASP-2336; ASP-2752; ILE-LEU-MET-ARG-2765 INS;
RP   MET-2768; LYS-2771; PRO-2816; SER-2858; 3012-THR--TYR-3017 DEL AND
RP   3748-LEU--ARG-3752 DEL, AND VARIANTS SER-2674; MET-2708; THR-2734;
RP   LEU-2735; CYS-2765; MET-2782; ARG-2814; GLY-2888; ILE-2905; ASP-2966
RP   AND LEU-3066.
RX   PubMed=11115377; DOI=10.1086/316939;
RA   Rossetti S., Strmecki L., Gamble V., Burton S., Sneddon V., Peral B.,
RA   Roy S., Bakkaloglu A., Komel R., Winearls C.G., Harris P.C.;
RT   "Mutation analysis of the entire PKD1 gene: genetic and diagnostic
RT   implications.";
RL   Am. J. Hum. Genet. 68:46-63(2001).
RN   [34]
RP   VARIANTS PKD1 LEU-2471; LEU-2519; GLY-2579 DEL; LEU-2613 DEL; ILE-2649
RP   AND PHE-2978 DEL, AND VARIANTS MET-2582; ARG-2638; ASN-2972 AND
RP   LEU-3066.
RX   PubMed=11571556; DOI=10.1038/sj.ejhg.5200696;
RA   Bouba I., Koptides M., Mean R., Costi C.-E., Demetriou K.,
RA   Georgiou I., Pierides A., Siamopoulos K., Deltas C.C.;
RT   "Novel PKD1 deletions and missense variants in a cohort of Hellenic
RT   polycystic kidney disease families.";
RL   Eur. J. Hum. Genet. 9:677-684(2001).
RN   [35]
RP   VARIANTS PKD1 ARG-967; ARG-2696; GLY-2985; CYS-3039 AND ILE-3285, AND
RP   VARIANTS VAL-88 AND ARG-3311.
RX   PubMed=11316854;
RA   Phakdeekitcharoen B., Watnick T.J., Germino G.G.;
RT   "Mutation analysis of the entire replicated portion of PKD1 using
RT   genomic DNA samples.";
RL   J. Am. Soc. Nephrol. 12:955-963(2001).
RN   [36]
RP   VARIANT PKD1 MET-3510, AND VARIANT MET-3008.
RX   PubMed=11558899; DOI=10.1007/s100380170032;
RA   Mizoguchi M., Tamura T., Yamaki A., Higashihara E., Shimizu Y.;
RT   "Mutations of the PKD1 gene among Japanese autosomal dominant
RT   polycystic kidney disease patients, including one heterozygous
RT   mutation identified in members of the same family.";
RL   J. Hum. Genet. 46:511-517(2001).
RN   [37]
RP   VARIANTS PKD1 ARG-3560; GLN-3719 AND TRP-3753, AND VARIANT MET-3510.
RX   PubMed=11691639; DOI=10.1016/S0027-5107(01)00226-3;
RA   Tsuchiya K., Komeda M., Takahashi M., Yamashita N., Cigira M.,
RA   Suzuki T., Suzuki K., Nihei H., Mochizuki T.;
RT   "Mutational analysis within the 3' region of the PKD1 gene in Japanese
RT   families.";
RL   Mutat. Res. 458:77-84(2001).
RN   [38]
RP   VARIANTS PKD1 SER-3602 AND SER-4255.
RX   PubMed=12220456; DOI=10.1034/j.1399-0004.2002.620211.x;
RA   Eo H.-S., Lee J.G., Ahn C., Cho J.T., Hwang D.Y., Hwang Y.H.,
RA   Lee E.J., Kim Y.S., Han J.S., Kim S., Lee J.S., Jeoung D.I., Lee S.E.,
RA   Kim U.K.;
RT   "Three novel mutations of the PKD1 gene in Korean patients with
RT   autosomal dominant polycystic kidney disease.";
RL   Clin. Genet. 62:169-174(2002).
RN   [39]
RP   VARIANTS PKD1 CYS-381; ASP-2185; THR-2421 DEL; ASP-2785 AND
RP   3027-THR--ARG-3039 DEL, AND VARIANTS GLN-739; THR-1092; ARG-1399;
RP   MET-1649; ARG-2638; CYS-2765 AND LEU-3066.
RX   PubMed=11857740; DOI=10.1002/humu.10045;
RA   McCluskey M., Schiavello T., Hunter M., Hantke J., Angelicheva D.,
RA   Bogdanova N., Markoff A., Thomas M., Dworniczak B., Horst J.,
RA   Kalaydjieva L.;
RT   "Mutation detection in the duplicated region of the polycystic kidney
RT   disease 1 (PKD1) gene in PKD1-linked Australian families.";
RL   Hum. Mutat. 19:240-250(2002).
RN   [40]
RP   VARIANTS PKD1 ILE-2083; ARG-2814 AND PRO-2816, AND VARIANTS MET-87 AND
RP   MET-3510.
RX   PubMed=12007219; DOI=10.1002/humu.10080;
RA   Inoue S., Inoue K., Utsunomiya M., Nozaki J., Yamada Y., Iwasa T.,
RA   Mori E., Yoshinaga T., Koizumi A.;
RT   "Mutation analysis in PKD1 of Japanese autosomal dominant polycystic
RT   kidney disease patients.";
RL   Hum. Mutat. 19:622-628(2002).
RN   [41]
RP   VARIANT PKD1 HIS-987, AND VARIANTS ARG-1399 AND VAL-4045.
RX   PubMed=12070253; DOI=10.1136/jmg.39.6.422;
RA   Burtey S., Lossi A.M., Bayle J., Berland Y., Fontes M.;
RT   "Mutation screening of the PKD1 transcript by RT-PCR.";
RL   J. Med. Genet. 39:422-429(2002).
RN   [42]
RP   VARIANTS PKD1 TRP-1340; LYS-1811; CYS-2092; ILE-2260 DEL; PHE-3167 AND
RP   PRO-3852, AND VARIANTS LEU-61; SER-572; THR-1092; SER-1168; ARG-1399;
RP   LEU-1684; ILE-1943; ARG-2638; SER-2674; MET-2708; ARG-2814; LEU-2958;
RP   ASN-2977; MET-3057; GLN-3435; VAL-3512; VAL-4045; VAL-4059; SER-4124;
RP   ILE-4146 AND PHE-4190.
RX   PubMed=11967008; DOI=10.1046/j.1523-1755.2002.00326.x;
RA   Rossetti S., Chauveau D., Walker D., Saggar-Malik A., Winearls C.G.,
RA   Torres V.E., Harris P.C.;
RT   "A complete mutation screen of the ADPKD genes by DHPLC.";
RL   Kidney Int. 61:1588-1599(2002).
RN   [43]
RP   VARIANTS PKD1 ASP-3632; LEU-3649 AND THR-3678, AND VARIANTS VAL-4045;
RP   VAL-4059; GLU-4102; PRO-4106 AND ILE-4146.
RX   PubMed=11773467; DOI=10.1093/ndt/17.1.75;
RA   Ding L., Zhang S., Qiu W., Xiao C., Wu S., Zhang G., Cheng L.,
RA   Zhang S.;
RT   "Novel mutations of PKD1 gene in Chinese patients with autosomal
RT   dominant polycystic kidney disease.";
RL   Nephrol. Dial. Transplant. 17:75-80(2002).
RN   [44]
RP   VARIANTS PKD1 ARG-164; GLY-210; ARG-508; ASP-690; ASN-1240 DEL;
RP   PRO-1667; LYS-1811; CYS-2092; CYS-2200; ILE-2260 DEL; ARG-2370;
RP   TYR-2373; LYS-2771; LEU-2802; ASN-3188 DEL; LEU-3355; PRO-3682 AND
RP   ARG-3751.
RX   PubMed=12842373; DOI=10.1016/S0140-6736(03)13773-7;
RA   Rossetti S., Chauveau D., Kubly V., Slezak J.M., Saggar-Malik A.K.,
RA   Pei Y., Ong A.C.M., Stewart F., Watson M.L., Bergstralh E.J.,
RA   Winearls C.G., Torres V.E., Harris P.C.;
RT   "Association of mutation position in polycystic kidney disease 1
RT   (PKD1) gene and development of a vascular phenotype.";
RL   Lancet 361:2196-2201(2003).
RN   [45]
RP   VARIANTS PKD1 SER-845; MET-3138 AND PRO-3954, AND VARIANTS HIS-36;
RP   ARG-2638; LEU-3066; MET-3510; VAL-3512; VAL-4045 AND VAL-4059.
RX   PubMed=15772804; DOI=10.1007/s00109-005-0644-6;
RA   Peltola P., Lumiaho A., Miettinen R., Pihlajamaeki J., Sandford R.,
RA   Laakso M.;
RT   "Genetics and phenotypic characteristics of autosomal dominant
RT   polycystic kidney disease in Finns.";
RL   J. Mol. Med. 83:638-646(2005).
RN   [46]
RP   VARIANTS PKD1 LEU-61; ILE-99; TYR-594; THR-1092; MET-1242; CYS-2200;
RP   LYS-2422; ARG-2638; LEU-3066; SER-3726 AND VAL-4155, AND VARIANTS
RP   HIS-36; GLN-739; ARG-1399; THR-1516; THR-1871; VAL-1926; ASP-1952;
RP   MET-2708; ARG-2814; VAL-3512; VAL-4045 AND VAL-4059.
RX   PubMed=18837007; DOI=10.1002/humu.20842;
RA   Tan Y.-C., Blumenfeld J.D., Anghel R., Donahue S., Belenkaya R.,
RA   Balina M., Parker T., Levine D., Leonard D.G.B., Rennert H.;
RT   "Novel method for genomic analysis of PKD1 and PKD2 mutations in
RT   autosomal dominant polycystic kidney disease.";
RL   Hum. Mutat. 30:264-273(2009).
RN   [47]
RP   VARIANTS PKD1 GLY-97; ARG-436; PRO-442; ARG-727; PRO-727; ASP-2391;
RP   TRP-2434; TYR-2546; CYS-2569; THR-2646; ARG-2889; PRO-3154; ARG-3603
RP   AND GLN-3750.
RX   PubMed=21115670; DOI=10.1093/ndt/gfq720;
RA   Hoefele J., Mayer K., Scholz M., Klein H.G.;
RT   "Novel PKD1 and PKD2 mutations in autosomal dominant polycystic kidney
RT   disease (ADPKD).";
RL   Nephrol. Dial. Transplant. 26:2181-2188(2011).
RN   [48]
RP   VARIANTS PKD1 CYS-325; TRP-611; ASP-698; PRO-727; GLY-1206; CYS-2379;
RP   CYS-2767; LYS-2771; ARG-2995; SER-3651; GLN-3750; TRP-3753; CYS-4150
RP   AND TRP-4276.
RX   PubMed=22508176; DOI=10.1002/humu.22103;
RA   Audrezet M.P., Gall E.C., Chen J.M., Redon S., Quere I., Creff J.,
RA   Benech C., Maestri S., Meur Y.L., Ferec C.;
RT   "Autosomal dominant polycystic kidney disease: Comprehensive mutation
RT   analysis of PKD1 and PKD2 in 700 unrelated patients.";
RL   Hum. Mutat. 33:1239-1250(2012).
CC   -!- FUNCTION: Involved in renal tubulogenesis (PubMed:12482949).
CC       Involved in fluid-flow mechanosensation by the primary cilium in
CC       renal epithelium (By similarity). Acts as a regulator of cilium
CC       length, together with PKD2 (By similarity). The dynamic control of
CC       cilium length is essential in the regulation of
CC       mechanotransductive signaling (By similarity). The cilium length
CC       response creates a negative feedback loop whereby fluid shear-
CC       mediated deflection of the primary cilium, which decreases
CC       intracellular cAMP, leads to cilium shortening and thus decreases
CC       flow-induced signaling (By similarity). May be an ion-channel
CC       regulator. Involved in adhesive protein-protein and protein-
CC       carbohydrate interactions. {ECO:0000250|UniProtKB:O08852,
CC       ECO:0000269|PubMed:12482949}.
CC   -!- SUBUNIT: Interacts with PKD2 and PKD2L1 (By similarity). Interacts
CC       with PRKX; involved in differentiation and controlled
CC       morphogenesis of the kidney (PubMed:17980165). Interacts with
CC       NPHP1 (via SH3 domain) (PubMed:20856870). Interacts with BBS1,
CC       BBS4, BBS5 and TTC8 (PubMed:24939912). Interacts with RGS7
CC       (PubMed:10339594). {ECO:0000250|UniProtKB:O08852,
CC       ECO:0000269|PubMed:10339594, ECO:0000269|PubMed:17980165,
CC       ECO:0000269|PubMed:20856870, ECO:0000269|PubMed:24939912}.
CC   -!- INTERACTION:
CC       O15259:NPHP1; NbExp=2; IntAct=EBI-1752013, EBI-953828;
CC       Q13563:PKD2; NbExp=8; IntAct=EBI-1752013, EBI-7813714;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:10339594,
CC       ECO:0000269|PubMed:20980620}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:20980620}. Cell projection, cilium
CC       {ECO:0000250|UniProtKB:O08852}. Note=PKD1 localization to the
CC       plasma and ciliary membranes requires PKD2, is independent of PKD2
CC       channel activity, and involves stimulation of PKD1 autoproteolytic
CC       cleavage at the GPS domain (By similarity). Ciliary localization
CC       of PKD1 requires BBS1 and ARL6/BBS3 (By similarity).
CC       {ECO:0000250|UniProtKB:O08852}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P98161-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P98161-2; Sequence=VSP_009677, VSP_009678;
CC       Name=3;
CC         IsoId=P98161-3; Sequence=VSP_009678;
CC   -!- DOMAIN: The LDL-receptor class A domain is atypical; the potential
CC       calcium-binding site is missing.
CC   -!- PTM: After synthesis, undergoes cleavage between Leu-3048 and Thr-
CC       3049 in the GPS domain. Cleavage at the GPS domain occurs through
CC       a cis-autoproteolytic mechanism involving an ester-intermediate
CC       via N-O acyl rearrangement. This process takes place in the early
CC       secretory pathway, depends on initial N-glycosylation, and
CC       requires the REJ domain. There is evidence that cleavage at GPS
CC       domain is incomplete. Uncleaved and cleaved products may have
CC       different functions in vivo. {ECO:0000269|PubMed:12482949}.
CC   -!- DISEASE: Polycystic kidney disease 1 (PKD1) [MIM:173900]: A
CC       disorder characterized by renal cysts, liver cysts and
CC       intracranial aneurysm. Clinical variability is due to differences
CC       in the rate of loss of glomerular filtration, the age of reaching
CC       end-stage renal disease and the occurrence of hypertension,
CC       symptomatic extrarenal cysts, and subarachnoid hemorrhage from
CC       intracranial 'berry' aneurysm. {ECO:0000269|PubMed:10200984,
CC       ECO:0000269|PubMed:10364515, ECO:0000269|PubMed:10577909,
CC       ECO:0000269|PubMed:10647901, ECO:0000269|PubMed:10729710,
CC       ECO:0000269|PubMed:10854095, ECO:0000269|PubMed:10923040,
CC       ECO:0000269|PubMed:10987650, ECO:0000269|PubMed:11012875,
CC       ECO:0000269|PubMed:11058904, ECO:0000269|PubMed:11115377,
CC       ECO:0000269|PubMed:11216660, ECO:0000269|PubMed:11316854,
CC       ECO:0000269|PubMed:11558899, ECO:0000269|PubMed:11571556,
CC       ECO:0000269|PubMed:11691639, ECO:0000269|PubMed:11773467,
CC       ECO:0000269|PubMed:11857740, ECO:0000269|PubMed:11967008,
CC       ECO:0000269|PubMed:12007219, ECO:0000269|PubMed:12070253,
CC       ECO:0000269|PubMed:12220456, ECO:0000269|PubMed:12842373,
CC       ECO:0000269|PubMed:15772804, ECO:0000269|PubMed:18837007,
CC       ECO:0000269|PubMed:21115670, ECO:0000269|PubMed:22508176,
CC       ECO:0000269|PubMed:8554072, ECO:0000269|PubMed:9199561,
CC       ECO:0000269|PubMed:9259200, ECO:0000269|PubMed:9285784,
CC       ECO:0000269|PubMed:9521593, ECO:0000269|PubMed:9921908}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the polycystin family. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 C-type lectin domain. {ECO:0000255|PROSITE-
CC       ProRule:PRU00040}.
CC   -!- SIMILARITY: Contains 1 GPS domain. {ECO:0000255|PROSITE-
CC       ProRule:PRU00098}.
CC   -!- SIMILARITY: Contains 1 LDL-receptor class A domain. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 2 LRR (leucine-rich) repeats. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 LRRCT domain. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 LRRNT domain. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 17 PKD domains. {ECO:0000255|PROSITE-
CC       ProRule:PRU00151}.
CC   -!- SIMILARITY: Contains 1 PLAT domain. {ECO:0000255|PROSITE-
CC       ProRule:PRU00152}.
CC   -!- SIMILARITY: Contains 1 REJ domain. {ECO:0000255|PROSITE-
CC       ProRule:PRU00511}.
CC   -!- SIMILARITY: Contains 1 WSC domain. {ECO:0000255|PROSITE-
CC       ProRule:PRU00558}.
CC   -!- CAUTION: Variant Cys-2379 has been originally described as a
CC       benign polymorphism (PubMed:10854095). However, it is a likely
CC       pathogenic mutation (PubMed:22508176).
CC       {ECO:0000305|PubMed:10854095, ECO:0000305|PubMed:22508176}.
CC   -!- WEB RESOURCE: Name=Functional Glycomics Gateway - Glycan Binding;
CC       Note=Polycystin-1;
CC       URL="http://www.functionalglycomics.org/glycomics/GBPServlet?&operationType=view&cbpId=cbp_hum_Ctlect_204";
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/PKD1ID41725ch16p13.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U24497; AAC50128.1; -; mRNA.
DR   EMBL; L33243; AAC37576.1; -; mRNA.
DR   EMBL; L43619; AAC41765.1; -; Genomic_DNA.
DR   EMBL; L43601; AAC41765.1; JOINED; Genomic_DNA.
DR   EMBL; L43602; AAC41765.1; JOINED; Genomic_DNA.
DR   EMBL; L43604; AAC41765.1; JOINED; Genomic_DNA.
DR   EMBL; L43605; AAC41765.1; JOINED; Genomic_DNA.
DR   EMBL; L43610; AAC41765.1; JOINED; Genomic_DNA.
DR   EMBL; L43617; AAC41765.1; JOINED; Genomic_DNA.
DR   EMBL; L43618; AAC41765.1; JOINED; Genomic_DNA.
DR   EMBL; AC093513; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC009065; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS32369.1; -. [P98161-1]
DR   CCDS; CCDS45385.1; -. [P98161-3]
DR   PIR; A38971; A38971.
DR   RefSeq; NP_000287.3; NM_000296.3.
DR   RefSeq; NP_001009944.2; NM_001009944.2.
DR   UniGene; Hs.75813; -.
DR   PDB; 1B4R; NMR; -; A=275-354.
DR   PDBsum; 1B4R; -.
DR   ProteinModelPortal; P98161; -.
DR   SMR; P98161; 275-354.
DR   BioGrid; 111327; 18.
DR   DIP; DIP-52317N; -.
DR   IntAct; P98161; 7.
DR   MINT; MINT-1199187; -.
DR   STRING; 9606.ENSP00000262304; -.
DR   ChEMBL; CHEMBL5772; -.
DR   MEROPS; P02.038; -.
DR   TCDB; 1.A.5.1.1; the polycystin cation channel (pcc) family.
DR   iPTMnet; P98161; -.
DR   PhosphoSite; P98161; -.
DR   BioMuta; PKD1; -.
DR   DMDM; 292495072; -.
DR   MaxQB; P98161; -.
DR   PaxDb; P98161; -.
DR   PRIDE; P98161; -.
DR   Ensembl; ENST00000262304; ENSP00000262304; ENSG00000008710. [P98161-1]
DR   Ensembl; ENST00000423118; ENSP00000399501; ENSG00000008710. [P98161-3]
DR   GeneID; 5310; -.
DR   KEGG; hsa:5310; -.
DR   UCSC; uc002cos.1; human. [P98161-1]
DR   CTD; 5310; -.
DR   GeneCards; PKD1; -.
DR   GeneReviews; PKD1; -.
DR   H-InvDB; HIX0173395; -.
DR   H-InvDB; HIX0202314; -.
DR   HGNC; HGNC:9008; PKD1.
DR   HPA; CAB046448; -.
DR   MalaCards; PKD1; -.
DR   MIM; 173900; phenotype.
DR   MIM; 601313; gene+phenotype.
DR   neXtProt; NX_P98161; -.
DR   Orphanet; 730; Autosomal dominant polycystic kidney disease.
DR   Orphanet; 88924; Autosomal dominant polycystic kidney disease type 1 with tuberous sclerosis.
DR   PharmGKB; PA35521; -.
DR   eggNOG; KOG3599; Eukaryota.
DR   eggNOG; ENOG410XTGE; LUCA.
DR   GeneTree; ENSGT00700000104221; -.
DR   HOGENOM; HOG000168445; -.
DR   HOVERGEN; HBG049412; -.
DR   InParanoid; P98161; -.
DR   KO; K04985; -.
DR   OMA; VSCKAQS; -.
DR   OrthoDB; EOG76X5Z6; -.
DR   PhylomeDB; P98161; -.
DR   TreeFam; TF316484; -.
DR   Reactome; R-HSA-5620916; VxPx cargo-targeting to cilium.
DR   SignaLink; P98161; -.
DR   EvolutionaryTrace; P98161; -.
DR   GeneWiki; PKD1; -.
DR   GenomeRNAi; 5310; -.
DR   NextBio; 20530; -.
DR   PRO; PR:P98161; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; P98161; -.
DR   CleanEx; HS_PKD1; -.
DR   ExpressionAtlas; P98161; baseline and differential.
DR   Genevisible; P98161; HS.
DR   GO; GO:0016323; C:basolateral plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0009986; C:cell surface; IEA:Ensembl.
DR   GO; GO:0060170; C:ciliary membrane; TAS:Reactome.
DR   GO; GO:0005929; C:cilium; ISS:BHF-UCL.
DR   GO; GO:0005737; C:cytoplasm; ISS:BHF-UCL.
DR   GO; GO:0005829; C:cytosol; IEA:Ensembl.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0030660; C:Golgi-associated vesicle membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; NAS:BHF-UCL.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0016328; C:lateral plasma membrane; IEA:Ensembl.
DR   GO; GO:0031512; C:motile primary cilium; ISS:BHF-UCL.
DR   GO; GO:0005634; C:nucleus; ISS:BHF-UCL.
DR   GO; GO:0005886; C:plasma membrane; IDA:MGI.
DR   GO; GO:0002133; C:polycystin complex; ISS:BHF-UCL.
DR   GO; GO:0072372; C:primary cilium; ISS:UniProtKB.
DR   GO; GO:0005262; F:calcium channel activity; ISS:BHF-UCL.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:UniProtKB-KW.
DR   GO; GO:0044325; F:ion channel binding; IPI:BHF-UCL.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:BHF-UCL.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc.
DR   GO; GO:0048754; P:branching morphogenesis of an epithelial tube; IDA:UniProtKB.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; ISS:BHF-UCL.
DR   GO; GO:0007161; P:calcium-independent cell-matrix adhesion; TAS:ProtInc.
DR   GO; GO:0001502; P:cartilage condensation; IEA:Ensembl.
DR   GO; GO:0051216; P:cartilage development; IEP:UniProtKB.
DR   GO; GO:0007050; P:cell cycle arrest; ISS:BHF-UCL.
DR   GO; GO:0007160; P:cell-matrix adhesion; TAS:ProtInc.
DR   GO; GO:0042994; P:cytoplasmic sequestering of transcription factor; ISS:BHF-UCL.
DR   GO; GO:0050982; P:detection of mechanical stimulus; ISS:BHF-UCL.
DR   GO; GO:0048565; P:digestive tract development; IEP:UniProtKB.
DR   GO; GO:0001892; P:embryonic placenta development; ISS:BHF-UCL.
DR   GO; GO:0030010; P:establishment of cell polarity; IEA:Ensembl.
DR   GO; GO:0048806; P:genitalia development; IEP:UniProtKB.
DR   GO; GO:0007507; P:heart development; IEP:UniProtKB.
DR   GO; GO:0007156; P:homophilic cell adhesion via plasma membrane adhesion molecules; TAS:ProtInc.
DR   GO; GO:0001701; P:in utero embryonic development; ISS:BHF-UCL.
DR   GO; GO:0007259; P:JAK-STAT cascade; ISS:BHF-UCL.
DR   GO; GO:0001822; P:kidney development; ISS:BHF-UCL.
DR   GO; GO:0001889; P:liver development; IEA:Ensembl.
DR   GO; GO:0060428; P:lung epithelium development; IEP:UniProtKB.
DR   GO; GO:0036303; P:lymph vessel morphogenesis; IEA:Ensembl.
DR   GO; GO:0072177; P:mesonephric duct development; IEP:UniProtKB.
DR   GO; GO:0072164; P:mesonephric tubule development; IEP:UniProtKB.
DR   GO; GO:0072218; P:metanephric ascending thin limb development; IEP:UniProtKB.
DR   GO; GO:0072205; P:metanephric collecting duct development; IEP:UniProtKB.
DR   GO; GO:0072287; P:metanephric distal tubule morphogenesis; IEP:UniProtKB.
DR   GO; GO:0072237; P:metanephric proximal tubule development; IEP:UniProtKB.
DR   GO; GO:0021915; P:neural tube development; IEP:UniProtKB.
DR   GO; GO:0006807; P:nitrogen compound metabolic process; IEA:Ensembl.
DR   GO; GO:0006996; P:organelle organization; TAS:Reactome.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; ISS:BHF-UCL.
DR   GO; GO:0060674; P:placenta blood vessel development; ISS:BHF-UCL.
DR   GO; GO:0031659; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle; IDA:BHF-UCL.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IEA:Ensembl.
DR   GO; GO:0032092; P:positive regulation of protein binding; ISS:BHF-UCL.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL.
DR   GO; GO:0006611; P:protein export from nucleus; ISS:BHF-UCL.
DR   GO; GO:0030155; P:regulation of cell adhesion; IEA:Ensembl.
DR   GO; GO:0060236; P:regulation of mitotic spindle organization; IEA:Ensembl.
DR   GO; GO:0061136; P:regulation of proteasomal protein catabolic process; IDA:MGI.
DR   GO; GO:0034405; P:response to fluid shear stress; IEA:Ensembl.
DR   GO; GO:0016337; P:single organismal cell-cell adhesion; IEA:Ensembl.
DR   GO; GO:0043588; P:skin development; IEP:UniProtKB.
DR   GO; GO:0021510; P:spinal cord development; IEP:UniProtKB.
DR   Gene3D; 2.60.40.670; -; 14.
DR   Gene3D; 2.60.60.20; -; 1.
DR   Gene3D; 3.10.100.10; -; 2.
DR   Gene3D; 3.80.10.10; -; 1.
DR   InterPro; IPR001304; C-type_lectin.
DR   InterPro; IPR016186; C-type_lectin-like.
DR   InterPro; IPR016187; C-type_lectin_fold.
DR   InterPro; IPR000483; Cys-rich_flank_reg_C.
DR   InterPro; IPR000203; GPS.
DR   InterPro; IPR032675; L_dom-like.
DR   InterPro; IPR001611; Leu-rich_rpt.
DR   InterPro; IPR003591; Leu-rich_rpt_typical-subtyp.
DR   InterPro; IPR000372; LRRNT.
DR   InterPro; IPR000434; PC1.
DR   InterPro; IPR022409; PKD/Chitinase_dom.
DR   InterPro; IPR002859; PKD/REJ-like.
DR   InterPro; IPR013122; PKD1_2_channel.
DR   InterPro; IPR000601; PKD_dom.
DR   InterPro; IPR001024; PLAT/LH2_dom.
DR   InterPro; IPR006228; Polycystin_cat.
DR   InterPro; IPR014010; REJ_dom.
DR   InterPro; IPR002889; WSC_carb-bd.
DR   InterPro; IPR013994; WSC_carb-bd_subgr.
DR   Pfam; PF00059; Lectin_C; 1.
DR   Pfam; PF13855; LRR_8; 1.
DR   Pfam; PF00801; PKD; 15.
DR   Pfam; PF08016; PKD_channel; 1.
DR   Pfam; PF01477; PLAT; 1.
DR   Pfam; PF02010; REJ; 1.
DR   Pfam; PF01822; WSC; 1.
DR   PRINTS; PR00500; POLYCYSTIN1.
DR   SMART; SM00034; CLECT; 1.
DR   SMART; SM00303; GPS; 1.
DR   SMART; SM00308; LH2; 1.
DR   SMART; SM00369; LRR_TYP; 1.
DR   SMART; SM00082; LRRCT; 1.
DR   SMART; SM00013; LRRNT; 1.
DR   SMART; SM00089; PKD; 15.
DR   SMART; SM00321; WSC; 1.
DR   SUPFAM; SSF49299; SSF49299; 13.
DR   SUPFAM; SSF49723; SSF49723; 1.
DR   SUPFAM; SSF52058; SSF52058; 1.
DR   SUPFAM; SSF56436; SSF56436; 1.
DR   TIGRFAMs; TIGR00864; PCC; 1.
DR   PROSITE; PS50041; C_TYPE_LECTIN_2; 1.
DR   PROSITE; PS50221; GPS; 1.
DR   PROSITE; PS51450; LRR; 2.
DR   PROSITE; PS50093; PKD; 12.
DR   PROSITE; PS50095; PLAT; 1.
DR   PROSITE; PS51111; REJ; 1.
DR   PROSITE; PS51212; WSC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Autocatalytic cleavage;
KW   Cell membrane; Cell projection; Ciliopathy; Cilium; Coiled coil;
KW   Complete proteome; Disease mutation; Disulfide bond; Glycoprotein;
KW   Lectin; Leucine-rich repeat; Membrane; Phosphoprotein; Polymorphism;
KW   Reference proteome; Repeat; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     23       {ECO:0000255}.
FT   CHAIN        24   4303       Polycystin-1.
FT                                /FTId=PRO_0000024298.
FT   TOPO_DOM     24   3074       Extracellular. {ECO:0000255}.
FT   TRANSMEM   3075   3095       Helical. {ECO:0000255}.
FT   TOPO_DOM   3096   3282       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   3283   3303       Helical. {ECO:0000255}.
FT   TOPO_DOM   3304   3323       Extracellular. {ECO:0000255}.
FT   TRANSMEM   3324   3344       Helical. {ECO:0000255}.
FT   TOPO_DOM   3345   3559       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   3560   3580       Helical. {ECO:0000255}.
FT   TOPO_DOM   3581   3582       Extracellular. {ECO:0000255}.
FT   TRANSMEM   3583   3603       Helical. {ECO:0000255}.
FT   TOPO_DOM   3604   3673       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   3674   3694       Helical. {ECO:0000255}.
FT   TOPO_DOM   3695   3896       Extracellular. {ECO:0000255}.
FT   TRANSMEM   3897   3917       Helical. {ECO:0000255}.
FT   TOPO_DOM   3918   3938       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   3939   3959       Helical. {ECO:0000255}.
FT   TOPO_DOM   3960   3979       Extracellular. {ECO:0000255}.
FT   TRANSMEM   3980   4000       Helical. {ECO:0000255}.
FT   TOPO_DOM   4001   4027       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   4028   4048       Helical. {ECO:0000255}.
FT   TOPO_DOM   4049   4085       Extracellular. {ECO:0000255}.
FT   TRANSMEM   4086   4106       Helical. {ECO:0000255}.
FT   TOPO_DOM   4107   4303       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       24     67       LRRNT.
FT   REPEAT       68     91       LRR 1.
FT   REPEAT       92    113       LRR 2.
FT   DOMAIN      125    178       LRRCT.
FT   DOMAIN      177    271       WSC. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00558}.
FT   DOMAIN      272    359       PKD 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00151}.
FT   DOMAIN      415    531       C-type lectin. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00040}.
FT   DOMAIN      638    671       LDL-receptor class A; atypical.
FT   DOMAIN      743    817       PKD 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00151}.
FT   DOMAIN      855    928       PKD 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00151}.
FT   DOMAIN      935   1020       PKD 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00151}.
FT   DOMAIN     1023   1129       PKD 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00151}.
FT   DOMAIN     1127   1215       PKD 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00151}.
FT   DOMAIN     1213   1298       PKD 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00151}.
FT   DOMAIN     1294   1383       PKD 8. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00151}.
FT   DOMAIN     1382   1469       PKD 9. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00151}.
FT   DOMAIN     1468   1551       PKD 10. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00151}.
FT   DOMAIN     1550   1635       PKD 11. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00151}.
FT   DOMAIN     1634   1721       PKD 12. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00151}.
FT   DOMAIN     1719   1805       PKD 13. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00151}.
FT   DOMAIN     1807   1890       PKD 14. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00151}.
FT   DOMAIN     1889   1974       PKD 15. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00151}.
FT   DOMAIN     1977   2057       PKD 16. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00151}.
FT   DOMAIN     2060   2148       PKD 17. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00151}.
FT   DOMAIN     2146   2833       REJ. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00511}.
FT   DOMAIN     3012   3061       GPS. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00098}.
FT   DOMAIN     3118   3233       PLAT. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00152}.
FT   COILED     4220   4251       {ECO:0000255}.
FT   MOTIF      3744   3756       Polycystin motif.
FT   SITE       3048   3049       Cleavage; by autolysis.
FT   MOD_RES    4166   4166       Phosphoserine; by PRKX; in vitro.
FT                                {ECO:0000269|PubMed:17980165}.
FT   CARBOHYD     50     50       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD     89     89       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    116    116       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    121    121       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    187    187       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    621    621       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    632    632       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    746    746       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    810    810       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    841    841       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    854    854       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    890    890       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    921    921       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   1004   1004       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   1010   1010       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   1034   1034       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   1072   1072       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   1113   1113       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   1178   1178       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   1194   1194       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   1240   1240       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   1269   1269       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   1336   1336       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   1348   1348       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   1382   1382       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   1450   1450       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   1455   1455       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   1474   1474       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   1518   1518       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   1541   1541       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   1554   1554       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   1563   1563       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   1647   1647       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   1661   1661       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   1733   1733       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   1791   1791       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   1834   1834       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   1867   1867       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   1880   1880       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   1991   1991       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   2050   2050       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   2074   2074       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   2125   2125       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   2248   2248       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   2353   2353       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   2395   2395       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   2412   2412       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   2567   2567       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   2578   2578       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   2645   2645       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   2718   2718       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   2754   2754       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   2841   2841       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   2878   2878       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   2925   2925       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   2956   2956       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   2994   2994       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   3738   3738       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   3790   3790       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   3845   3845       N-linked (GlcNAc...). {ECO:0000255}.
FT   DISULFID    436    530       {ECO:0000250}.
FT   DISULFID    508    522       {ECO:0000250}.
FT   DISULFID    640    653       {ECO:0000250}.
FT   DISULFID    647    665       {ECO:0000250}.
FT   DISULFID    660    669       {ECO:0000250}.
FT   VAR_SEQ    2497   2507       GWHDAEDAGAP -> A (in isoform 2).
FT                                {ECO:0000303|PubMed:7663510}.
FT                                /FTId=VSP_009677.
FT   VAR_SEQ    3390   3390       Missing (in isoform 2 and isoform 3).
FT                                {ECO:0000303|PubMed:7663510}.
FT                                /FTId=VSP_009678.
FT   VARIANT      13     13       L -> Q (in PKD1).
FT                                {ECO:0000269|PubMed:11115377}.
FT                                /FTId=VAR_011030.
FT   VARIANT      36     36       P -> H. {ECO:0000269|PubMed:15772804,
FT                                ECO:0000269|PubMed:18837007}.
FT                                /FTId=VAR_058759.
FT   VARIANT      61     61       P -> L (in PKD1; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:11967008,
FT                                ECO:0000269|PubMed:18837007}.
FT                                /FTId=VAR_058760.
FT   VARIANT      75     75       S -> F (in PKD1).
FT                                {ECO:0000269|PubMed:11115377}.
FT                                /FTId=VAR_011031.
FT   VARIANT      87     87       L -> M. {ECO:0000269|PubMed:12007219}.
FT                                /FTId=VAR_058761.
FT   VARIANT      88     88       A -> V. {ECO:0000269|PubMed:11316854}.
FT                                /FTId=VAR_012452.
FT   VARIANT      97     97       D -> G (in PKD1).
FT                                {ECO:0000269|PubMed:21115670}.
FT                                /FTId=VAR_064380.
FT   VARIANT      99     99       S -> I (in PKD1; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:18837007}.
FT                                /FTId=VAR_058762.
FT   VARIANT     139    139       W -> C (in PKD1).
FT                                {ECO:0000269|PubMed:11115377}.
FT                                /FTId=VAR_011032.
FT   VARIANT     164    164       Q -> R (in PKD1).
FT                                {ECO:0000269|PubMed:12842373}.
FT                                /FTId=VAR_058763.
FT   VARIANT     210    210       C -> G (in PKD1).
FT                                {ECO:0000269|PubMed:12842373}.
FT                                /FTId=VAR_058764.
FT   VARIANT     324    324       R -> L (in PKD1).
FT                                {ECO:0000269|PubMed:10364515}.
FT                                /FTId=VAR_010085.
FT   VARIANT     325    325       Y -> C (in PKD1).
FT                                {ECO:0000269|PubMed:22508176}.
FT                                /FTId=VAR_068024.
FT   VARIANT     381    381       G -> C (in PKD1).
FT                                {ECO:0000269|PubMed:11857740}.
FT                                /FTId=VAR_058765.
FT   VARIANT     436    436       C -> R (in PKD1).
FT                                {ECO:0000269|PubMed:21115670}.
FT                                /FTId=VAR_064381.
FT   VARIANT     442    442       A -> P (in PKD1).
FT                                {ECO:0000269|PubMed:21115670}.
FT                                /FTId=VAR_064382.
FT   VARIANT     508    508       C -> R (in PKD1; dbSNP:rs58598099).
FT                                {ECO:0000269|PubMed:12842373}.
FT                                /FTId=VAR_058766.
FT   VARIANT     572    572       P -> S (in dbSNP:rs149022148).
FT                                {ECO:0000269|PubMed:11967008}.
FT                                /FTId=VAR_058767.
FT   VARIANT     594    594       F -> Y (in PKD1).
FT                                {ECO:0000269|PubMed:18837007}.
FT                                /FTId=VAR_058768.
FT   VARIANT     611    611       R -> W (in PKD1).
FT                                {ECO:0000269|PubMed:22508176}.
FT                                /FTId=VAR_068025.
FT   VARIANT     690    690       V -> D (in PKD1).
FT                                {ECO:0000269|PubMed:12842373}.
FT                                /FTId=VAR_058769.
FT   VARIANT     698    698       Y -> D (in PKD1).
FT                                {ECO:0000269|PubMed:22508176}.
FT                                /FTId=VAR_068026.
FT   VARIANT     727    727       L -> P (in PKD1).
FT                                {ECO:0000269|PubMed:21115670,
FT                                ECO:0000269|PubMed:22508176}.
FT                                /FTId=VAR_064383.
FT   VARIANT     727    727       L -> R (in PKD1).
FT                                {ECO:0000269|PubMed:21115670}.
FT                                /FTId=VAR_064384.
FT   VARIANT     738    738       P -> R.
FT                                /FTId=VAR_058770.
FT   VARIANT     739    739       R -> Q (in dbSNP:rs40433).
FT                                {ECO:0000269|PubMed:11857740,
FT                                ECO:0000269|PubMed:18837007,
FT                                ECO:0000269|PubMed:7663510}.
FT                                /FTId=VAR_058771.
FT   VARIANT     845    845       L -> S (in PKD1).
FT                                {ECO:0000269|PubMed:10364515,
FT                                ECO:0000269|PubMed:15772804}.
FT                                /FTId=VAR_010086.
FT   VARIANT     950    950       L -> P (in dbSNP:rs2369063).
FT                                /FTId=VAR_056696.
FT   VARIANT     967    967       W -> R (in PKD1).
FT                                {ECO:0000269|PubMed:11316854}.
FT                                /FTId=VAR_012453.
FT   VARIANT     987    987       Q -> H (in PKD1).
FT                                {ECO:0000269|PubMed:12070253}.
FT                                /FTId=VAR_058772.
FT   VARIANT    1092   1092       M -> T (in PKD1; dbSNP:rs2549677).
FT                                {ECO:0000269|PubMed:11857740,
FT                                ECO:0000269|PubMed:11967008,
FT                                ECO:0000269|PubMed:18837007,
FT                                ECO:0000269|PubMed:7736581}.
FT                                /FTId=VAR_056697.
FT   VARIANT    1114   1114       L -> R (in dbSNP:rs241573).
FT                                /FTId=VAR_056698.
FT   VARIANT    1166   1166       G -> S (in PKD1).
FT                                {ECO:0000269|PubMed:11012875}.
FT                                /FTId=VAR_011033.
FT   VARIANT    1168   1168       P -> S (in dbSNP:rs146887330).
FT                                {ECO:0000269|PubMed:11967008}.
FT                                /FTId=VAR_058773.
FT   VARIANT    1206   1206       V -> G (in PKD1).
FT                                {ECO:0000269|PubMed:22508176}.
FT                                /FTId=VAR_068027.
FT   VARIANT    1240   1240       Missing (in PKD1).
FT                                {ECO:0000269|PubMed:12842373}.
FT                                /FTId=VAR_058774.
FT   VARIANT    1242   1242       T -> M (in PKD1; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:18837007}.
FT                                /FTId=VAR_058775.
FT   VARIANT    1340   1340       R -> W (in PKD1; dbSNP:rs143690392).
FT                                {ECO:0000269|PubMed:11967008}.
FT                                /FTId=VAR_058776.
FT   VARIANT    1399   1399       W -> R (in dbSNP:rs116092985).
FT                                {ECO:0000269|PubMed:10364515,
FT                                ECO:0000269|PubMed:10577909,
FT                                ECO:0000269|PubMed:11857740,
FT                                ECO:0000269|PubMed:11967008,
FT                                ECO:0000269|PubMed:12070253,
FT                                ECO:0000269|PubMed:18837007}.
FT                                /FTId=VAR_010087.
FT   VARIANT    1516   1516       A -> T (in dbSNP:rs148164067).
FT                                {ECO:0000269|PubMed:18837007}.
FT                                /FTId=VAR_058777.
FT   VARIANT    1557   1557       R -> P (in dbSNP:rs241572).
FT                                /FTId=VAR_056699.
FT   VARIANT    1649   1649       T -> M. {ECO:0000269|PubMed:11857740}.
FT                                /FTId=VAR_058778.
FT   VARIANT    1667   1667       T -> P (in PKD1).
FT                                {ECO:0000269|PubMed:12842373}.
FT                                /FTId=VAR_058779.
FT   VARIANT    1684   1684       S -> L (in dbSNP:rs139520275).
FT                                {ECO:0000269|PubMed:11967008}.
FT                                /FTId=VAR_058780.
FT   VARIANT    1734   1734       T -> K (in dbSNP:rs241571).
FT                                /FTId=VAR_056700.
FT   VARIANT    1786   1786       P -> L (rare polymorphism).
FT                                {ECO:0000269|PubMed:10364515}.
FT                                /FTId=VAR_010088.
FT   VARIANT    1811   1811       E -> K (in PKD1).
FT                                {ECO:0000269|PubMed:11967008,
FT                                ECO:0000269|PubMed:12842373}.
FT                                /FTId=VAR_058781.
FT   VARIANT    1871   1871       A -> T. {ECO:0000269|PubMed:18837007}.
FT                                /FTId=VAR_058782.
FT   VARIANT    1926   1926       A -> V. {ECO:0000269|PubMed:18837007}.
FT                                /FTId=VAR_058783.
FT   VARIANT    1943   1943       V -> I (in dbSNP:rs137978188).
FT                                {ECO:0000269|PubMed:11967008}.
FT                                /FTId=VAR_058784.
FT   VARIANT    1952   1952       G -> D. {ECO:0000269|PubMed:18837007}.
FT                                /FTId=VAR_058785.
FT   VARIANT    1956   1956       V -> E (in PKD1).
FT                                {ECO:0000269|PubMed:11012875}.
FT                                /FTId=VAR_011034.
FT   VARIANT    1992   1993       FT -> L (in PKD1).
FT                                {ECO:0000269|PubMed:11115377}.
FT                                /FTId=VAR_011035.
FT   VARIANT    1995   1995       R -> H. {ECO:0000269|PubMed:11012875}.
FT                                /FTId=VAR_011036.
FT   VARIANT    2083   2083       T -> I (in PKD1).
FT                                {ECO:0000269|PubMed:12007219}.
FT                                /FTId=VAR_058786.
FT   VARIANT    2092   2092       Y -> C (in PKD1).
FT                                {ECO:0000269|PubMed:11967008,
FT                                ECO:0000269|PubMed:12842373}.
FT                                /FTId=VAR_058787.
FT   VARIANT    2185   2185       Y -> D (in PKD1).
FT                                {ECO:0000269|PubMed:11857740}.
FT                                /FTId=VAR_058788.
FT   VARIANT    2200   2200       R -> C (in PKD1; dbSNP:rs140869992).
FT                                {ECO:0000269|PubMed:12842373,
FT                                ECO:0000269|PubMed:18837007}.
FT                                /FTId=VAR_058789.
FT   VARIANT    2220   2224       Missing (in PKD1).
FT                                {ECO:0000269|PubMed:11115377}.
FT                                /FTId=VAR_011037.
FT   VARIANT    2250   2250       T -> M (in PKD1; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:10854095}.
FT                                /FTId=VAR_011038.
FT   VARIANT    2260   2260       Missing (in PKD1).
FT                                {ECO:0000269|PubMed:11967008,
FT                                ECO:0000269|PubMed:12842373}.
FT                                /FTId=VAR_058790.
FT   VARIANT    2329   2329       R -> W (in PKD1; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:10854095}.
FT                                /FTId=VAR_011039.
FT   VARIANT    2336   2336       Y -> D (in PKD1).
FT                                {ECO:0000269|PubMed:11115377}.
FT                                /FTId=VAR_011040.
FT   VARIANT    2370   2370       C -> R (in PKD1).
FT                                {ECO:0000269|PubMed:12842373}.
FT                                /FTId=VAR_058791.
FT   VARIANT    2373   2373       C -> Y (in PKD1).
FT                                {ECO:0000269|PubMed:12842373}.
FT                                /FTId=VAR_058792.
FT   VARIANT    2379   2379       Y -> C (in PKD1).
FT                                {ECO:0000269|PubMed:10854095,
FT                                ECO:0000269|PubMed:22508176}.
FT                                /FTId=VAR_011041.
FT   VARIANT    2391   2391       G -> D (in PKD1).
FT                                {ECO:0000269|PubMed:21115670}.
FT                                /FTId=VAR_064385.
FT   VARIANT    2392   2392       R -> P (in PKD1).
FT                                {ECO:0000269|PubMed:10577909}.
FT                                /FTId=VAR_012454.
FT   VARIANT    2408   2408       R -> C (in PKD1).
FT                                {ECO:0000269|PubMed:11012875}.
FT                                /FTId=VAR_011042.
FT   VARIANT    2421   2421       Missing (in PKD1).
FT                                {ECO:0000269|PubMed:11857740}.
FT                                /FTId=VAR_058793.
FT   VARIANT    2422   2422       T -> K (in PKD1).
FT                                {ECO:0000269|PubMed:18837007}.
FT                                /FTId=VAR_058794.
FT   VARIANT    2423   2423       S -> F (in PKD1).
FT                                {ECO:0000269|PubMed:10577909}.
FT                                /FTId=VAR_012455.
FT   VARIANT    2434   2434       R -> W (in PKD1).
FT                                {ECO:0000269|PubMed:21115670}.
FT                                /FTId=VAR_064386.
FT   VARIANT    2443   2443       G -> GG (in PKD1).
FT                                /FTId=VAR_011043.
FT   VARIANT    2471   2471       P -> L (in PKD1).
FT                                {ECO:0000269|PubMed:11571556}.
FT                                /FTId=VAR_012456.
FT   VARIANT    2515   2515       R -> Q (in dbSNP:rs2432404).
FT                                /FTId=VAR_056701.
FT   VARIANT    2519   2519       Q -> L (in PKD1; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:11571556}.
FT                                /FTId=VAR_012457.
FT   VARIANT    2534   2534       S -> G (in dbSNP:rs3874655).
FT                                /FTId=VAR_056702.
FT   VARIANT    2546   2546       H -> Y (in PKD1).
FT                                {ECO:0000269|PubMed:21115670}.
FT                                /FTId=VAR_064387.
FT   VARIANT    2548   2548       E -> Q (in dbSNP:rs28369051).
FT                                {ECO:0000269|PubMed:10577909}.
FT                                /FTId=VAR_012458.
FT   VARIANT    2569   2569       S -> C (in PKD1).
FT                                {ECO:0000269|PubMed:21115670}.
FT                                /FTId=VAR_064388.
FT   VARIANT    2579   2579       Missing (in PKD1; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:11571556}.
FT                                /FTId=VAR_012459.
FT   VARIANT    2582   2582       T -> M (in dbSNP:rs2432405).
FT                                {ECO:0000269|PubMed:11571556}.
FT                                /FTId=VAR_012460.
FT   VARIANT    2604   2604       D -> N. {ECO:0000269|PubMed:11012875}.
FT                                /FTId=VAR_011044.
FT   VARIANT    2613   2613       Missing (in PKD1; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:11571556}.
FT                                /FTId=VAR_012461.
FT   VARIANT    2638   2638       H -> R (in PKD1; dbSNP:rs9936785).
FT                                {ECO:0000269|PubMed:10577909,
FT                                ECO:0000269|PubMed:11571556,
FT                                ECO:0000269|PubMed:11857740,
FT                                ECO:0000269|PubMed:11967008,
FT                                ECO:0000269|PubMed:15772804,
FT                                ECO:0000269|PubMed:18837007}.
FT                                /FTId=VAR_012462.
FT   VARIANT    2646   2646       I -> T (in PKD1).
FT                                {ECO:0000269|PubMed:21115670}.
FT                                /FTId=VAR_064389.
FT   VARIANT    2649   2649       T -> I (in PKD1; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:11571556}.
FT                                /FTId=VAR_012463.
FT   VARIANT    2674   2674       P -> S. {ECO:0000269|PubMed:11115377,
FT                                ECO:0000269|PubMed:11967008}.
FT                                /FTId=VAR_011045.
FT   VARIANT    2696   2696       L -> R (in PKD1).
FT                                {ECO:0000269|PubMed:11316854}.
FT                                /FTId=VAR_012464.
FT   VARIANT    2708   2708       T -> M. {ECO:0000269|PubMed:11115377,
FT                                ECO:0000269|PubMed:11967008,
FT                                ECO:0000269|PubMed:18837007}.
FT                                /FTId=VAR_011046.
FT   VARIANT    2734   2734       P -> T (in dbSNP:rs150568356).
FT                                {ECO:0000269|PubMed:11115377}.
FT                                /FTId=VAR_011047.
FT   VARIANT    2735   2735       Q -> L (in dbSNP:rs141717814).
FT                                {ECO:0000269|PubMed:11115377}.
FT                                /FTId=VAR_011048.
FT   VARIANT    2746   2746       R -> P (in dbSNP:rs1800569).
FT                                /FTId=VAR_014918.
FT   VARIANT    2752   2752       A -> D (in PKD1).
FT                                {ECO:0000269|PubMed:11115377}.
FT                                /FTId=VAR_011049.
FT   VARIANT    2760   2760       M -> T (associated with PKD1;
FT                                dbSNP:rs1800568).
FT                                {ECO:0000269|PubMed:9285784}.
FT                                /FTId=VAR_005533.
FT   VARIANT    2761   2761       R -> P (associated with PKD1).
FT                                {ECO:0000269|PubMed:9285784}.
FT                                /FTId=VAR_058795.
FT   VARIANT    2763   2763       L -> V (in PKD1).
FT                                {ECO:0000269|PubMed:9285784}.
FT                                /FTId=VAR_005535.
FT   VARIANT    2764   2764       M -> T (associated with PKD1;
FT                                dbSNP:rs1800570).
FT                                {ECO:0000269|PubMed:9285784}.
FT                                /FTId=VAR_005536.
FT   VARIANT    2765   2765       R -> C (in dbSNP:rs144979397).
FT                                {ECO:0000269|PubMed:11115377,
FT                                ECO:0000269|PubMed:11857740}.
FT                                /FTId=VAR_011051.
FT   VARIANT    2765   2765       R -> RILMR (in PKD1).
FT                                /FTId=VAR_011050.
FT   VARIANT    2767   2767       R -> C (in PKD1).
FT                                {ECO:0000269|PubMed:22508176}.
FT                                /FTId=VAR_068028.
FT   VARIANT    2768   2768       V -> M (in PKD1; associated with S-2858).
FT                                {ECO:0000269|PubMed:11115377}.
FT                                /FTId=VAR_011052.
FT   VARIANT    2771   2771       E -> K (in PKD1; does not undergo
FT                                autoproteolytic cleavage).
FT                                {ECO:0000269|PubMed:11115377,
FT                                ECO:0000269|PubMed:12482949,
FT                                ECO:0000269|PubMed:12842373,
FT                                ECO:0000269|PubMed:22508176}.
FT                                /FTId=VAR_011053.
FT   VARIANT    2782   2782       V -> M. {ECO:0000269|PubMed:11115377}.
FT                                /FTId=VAR_011054.
FT   VARIANT    2785   2785       G -> D (in PKD1).
FT                                {ECO:0000269|PubMed:11857740}.
FT                                /FTId=VAR_058796.
FT   VARIANT    2791   2791       R -> Q (in a patient with polycystic
FT                                kidney disease; does not affect
FT                                autoproteolytic cleavage at the GPS
FT                                domain). {ECO:0000269|PubMed:12482949,
FT                                ECO:0000269|PubMed:9285784}.
FT                                /FTId=VAR_005537.
FT   VARIANT    2802   2802       P -> L (in PKD1).
FT                                {ECO:0000269|PubMed:12842373}.
FT                                /FTId=VAR_058797.
FT   VARIANT    2814   2814       G -> R (in PKD1; unknown pathological
FT                                significance; dbSNP:rs149151043).
FT                                {ECO:0000269|PubMed:11115377,
FT                                ECO:0000269|PubMed:11967008,
FT                                ECO:0000269|PubMed:12007219,
FT                                ECO:0000269|PubMed:18837007}.
FT                                /FTId=VAR_011055.
FT   VARIANT    2816   2816       L -> P (in PKD1).
FT                                {ECO:0000269|PubMed:11115377,
FT                                ECO:0000269|PubMed:12007219}.
FT                                /FTId=VAR_011056.
FT   VARIANT    2826   2826       I -> T (in PKD1).
FT                                {ECO:0000269|PubMed:9285784}.
FT                                /FTId=VAR_005538.
FT   VARIANT    2858   2858       G -> S (in PKD1; associated with M-2768).
FT                                {ECO:0000269|PubMed:11115377}.
FT                                /FTId=VAR_011057.
FT   VARIANT    2888   2888       R -> G. {ECO:0000269|PubMed:11115377}.
FT                                /FTId=VAR_011058.
FT   VARIANT    2889   2889       S -> R (in PKD1).
FT                                {ECO:0000269|PubMed:21115670}.
FT                                /FTId=VAR_064390.
FT   VARIANT    2905   2905       V -> I (in dbSNP:rs147788838).
FT                                {ECO:0000269|PubMed:11115377}.
FT                                /FTId=VAR_011059.
FT   VARIANT    2921   2921       H -> P (in PKD1; does not undergo
FT                                autoproteolytic cleavage).
FT                                {ECO:0000269|PubMed:10923040,
FT                                ECO:0000269|PubMed:12482949}.
FT                                /FTId=VAR_011060.
FT   VARIANT    2958   2958       S -> L. {ECO:0000269|PubMed:11967008}.
FT                                /FTId=VAR_058798.
FT   VARIANT    2966   2966       E -> D (in dbSNP:rs13337123).
FT                                {ECO:0000269|PubMed:11115377}.
FT                                /FTId=VAR_011061.
FT   VARIANT    2972   2972       D -> N. {ECO:0000269|PubMed:11571556}.
FT                                /FTId=VAR_012465.
FT   VARIANT    2977   2977       T -> N. {ECO:0000269|PubMed:11967008}.
FT                                /FTId=VAR_058799.
FT   VARIANT    2978   2978       Missing (in PKD1; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:11571556}.
FT                                /FTId=VAR_012466.
FT   VARIANT    2985   2985       R -> G (in PKD1).
FT                                {ECO:0000269|PubMed:11316854}.
FT                                /FTId=VAR_012467.
FT   VARIANT    2993   2993       L -> P (in PKD1; does not undergo
FT                                autoproteolytic cleavage).
FT                                {ECO:0000269|PubMed:12482949,
FT                                ECO:0000269|PubMed:9199561}.
FT                                /FTId=VAR_010089.
FT   VARIANT    2995   2995       L -> R (in PKD1).
FT                                {ECO:0000269|PubMed:22508176}.
FT                                /FTId=VAR_068029.
FT   VARIANT    3005   3005       Q -> E (in dbSNP:rs1063401).
FT                                /FTId=VAR_056703.
FT   VARIANT    3008   3008       V -> L (in PKD1).
FT                                {ECO:0000269|PubMed:9285784}.
FT                                /FTId=VAR_005539.
FT   VARIANT    3008   3008       V -> M (in dbSNP:rs117896488).
FT                                {ECO:0000269|PubMed:11558899}.
FT                                /FTId=VAR_058800.
FT   VARIANT    3012   3017       Missing (in PKD1).
FT                                {ECO:0000269|PubMed:11115377}.
FT                                /FTId=VAR_011062.
FT   VARIANT    3016   3016       Q -> R (in PKD1; does not undergo
FT                                autoproteolytic cleavage).
FT                                {ECO:0000269|PubMed:12482949,
FT                                ECO:0000269|PubMed:9199561}.
FT                                /FTId=VAR_010090.
FT   VARIANT    3023   3023       M -> V (in dbSNP:rs17135779).
FT                                /FTId=VAR_056704.
FT   VARIANT    3027   3039       Missing (in PKD1).
FT                                {ECO:0000269|PubMed:11857740}.
FT                                /FTId=VAR_058801.
FT   VARIANT    3039   3039       R -> C (in PKD1).
FT                                {ECO:0000269|PubMed:11316854}.
FT                                /FTId=VAR_012468.
FT   VARIANT    3057   3057       V -> M. {ECO:0000269|PubMed:11967008}.
FT                                /FTId=VAR_058802.
FT   VARIANT    3066   3066       F -> L (in PKD1; dbSNP:rs77028972).
FT                                {ECO:0000269|PubMed:10854095,
FT                                ECO:0000269|PubMed:10923040,
FT                                ECO:0000269|PubMed:11115377,
FT                                ECO:0000269|PubMed:11571556,
FT                                ECO:0000269|PubMed:11857740,
FT                                ECO:0000269|PubMed:15772804,
FT                                ECO:0000269|PubMed:18837007,
FT                                ECO:0000269|PubMed:9285784}.
FT                                /FTId=VAR_011063.
FT   VARIANT    3138   3138       V -> M (in PKD1; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:15772804}.
FT                                /FTId=VAR_058803.
FT   VARIANT    3139   3139       G -> V. {ECO:0000269|PubMed:10854095}.
FT                                /FTId=VAR_011064.
FT   VARIANT    3154   3154       L -> P (in PKD1).
FT                                {ECO:0000269|PubMed:21115670}.
FT                                /FTId=VAR_064391.
FT   VARIANT    3167   3167       I -> F (in PKD1).
FT                                {ECO:0000269|PubMed:11967008}.
FT                                /FTId=VAR_058804.
FT   VARIANT    3188   3188       Missing (in PKD1).
FT                                {ECO:0000269|PubMed:12842373}.
FT                                /FTId=VAR_058805.
FT   VARIANT    3193   3193       P -> L. {ECO:0000269|PubMed:10854095}.
FT                                /FTId=VAR_011065.
FT   VARIANT    3247   3247       R -> H (in PKD1).
FT                                {ECO:0000269|PubMed:11216660}.
FT                                /FTId=VAR_013838.
FT   VARIANT    3285   3285       V -> I (in PKD1).
FT                                {ECO:0000269|PubMed:11316854}.
FT                                /FTId=VAR_012469.
FT   VARIANT    3311   3311       H -> R. {ECO:0000269|PubMed:11316854}.
FT                                /FTId=VAR_012470.
FT   VARIANT    3355   3355       P -> L (in PKD1).
FT                                {ECO:0000269|PubMed:12842373}.
FT                                /FTId=VAR_058806.
FT   VARIANT    3375   3375       V -> M (in PKD1).
FT                                {ECO:0000269|PubMed:10923040,
FT                                ECO:0000269|PubMed:9921908}.
FT                                /FTId=VAR_005541.
FT   VARIANT    3382   3382       T -> M (in PKD1).
FT                                {ECO:0000269|PubMed:11216660}.
FT                                /FTId=VAR_013839.
FT   VARIANT    3435   3435       R -> Q (in dbSNP:rs140189010).
FT                                {ECO:0000269|PubMed:11967008}.
FT                                /FTId=VAR_058807.
FT   VARIANT    3510   3510       T -> M (in PKD1; dbSNP:rs45478794).
FT                                {ECO:0000269|PubMed:11558899,
FT                                ECO:0000269|PubMed:11691639,
FT                                ECO:0000269|PubMed:12007219,
FT                                ECO:0000269|PubMed:15772804,
FT                                ECO:0000269|PubMed:9199561}.
FT                                /FTId=VAR_010091.
FT   VARIANT    3511   3511       L -> V (in PKD1; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:9199561}.
FT                                /FTId=VAR_010092.
FT   VARIANT    3512   3512       A -> V (in dbSNP:rs34197769).
FT                                {ECO:0000269|PubMed:11967008,
FT                                ECO:0000269|PubMed:15772804,
FT                                ECO:0000269|PubMed:18837007}.
FT                                /FTId=VAR_011066.
FT   VARIANT    3560   3560       G -> R (in PKD1; dbSNP:rs79000340).
FT                                {ECO:0000269|PubMed:11691639}.
FT                                /FTId=VAR_012471.
FT   VARIANT    3562   3562       S -> N.
FT                                /FTId=VAR_010093.
FT   VARIANT    3602   3602       G -> S (in PKD1).
FT                                {ECO:0000269|PubMed:12220456}.
FT                                /FTId=VAR_058808.
FT   VARIANT    3603   3603       W -> R (in PKD1).
FT                                {ECO:0000269|PubMed:21115670}.
FT                                /FTId=VAR_064392.
FT   VARIANT    3632   3632       E -> D (in PKD1).
FT                                {ECO:0000269|PubMed:11773467,
FT                                ECO:0000269|PubMed:8554072}.
FT                                /FTId=VAR_005542.
FT   VARIANT    3649   3649       P -> L (in PKD1).
FT                                {ECO:0000269|PubMed:11773467}.
FT                                /FTId=VAR_058809.
FT   VARIANT    3651   3651       G -> S (in PKD1).
FT                                {ECO:0000269|PubMed:22508176}.
FT                                /FTId=VAR_068030.
FT   VARIANT    3678   3678       M -> T (in PKD1).
FT                                {ECO:0000269|PubMed:11773467,
FT                                ECO:0000269|PubMed:9259200}.
FT                                /FTId=VAR_005543.
FT   VARIANT    3682   3682       L -> P (in PKD1).
FT                                {ECO:0000269|PubMed:12842373}.
FT                                /FTId=VAR_058810.
FT   VARIANT    3719   3719       R -> Q (in PKD1).
FT                                {ECO:0000269|PubMed:11058904,
FT                                ECO:0000269|PubMed:11691639}.
FT                                /FTId=VAR_011067.
FT   VARIANT    3726   3726       W -> S (in PKD1; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:18837007}.
FT                                /FTId=VAR_058811.
FT   VARIANT    3748   3752       Missing (in PKD1).
FT                                {ECO:0000269|PubMed:10647901,
FT                                ECO:0000269|PubMed:8554072}.
FT                                /FTId=VAR_005544.
FT   VARIANT    3750   3750       R -> Q (in PKD1).
FT                                {ECO:0000269|PubMed:21115670,
FT                                ECO:0000269|PubMed:22508176}.
FT                                /FTId=VAR_064393.
FT   VARIANT    3751   3751       Q -> R (in PKD1).
FT                                {ECO:0000269|PubMed:12842373}.
FT                                /FTId=VAR_058812.
FT   VARIANT    3753   3753       R -> W (in PKD1).
FT                                {ECO:0000269|PubMed:10729710,
FT                                ECO:0000269|PubMed:11691639,
FT                                ECO:0000269|PubMed:22508176}.
FT                                /FTId=VAR_011068.
FT   VARIANT    3815   3815       D -> N (in PKD1).
FT                                {ECO:0000269|PubMed:10729710}.
FT                                /FTId=VAR_011069.
FT   VARIANT    3852   3852       L -> P (in PKD1).
FT                                {ECO:0000269|PubMed:11058904,
FT                                ECO:0000269|PubMed:11967008}.
FT                                /FTId=VAR_011070.
FT   VARIANT    3954   3954       A -> P (in PKD1; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:15772804}.
FT                                /FTId=VAR_058813.
FT   VARIANT    3996   3996       F -> FLLF (in PKD1).
FT                                /FTId=VAR_010094.
FT   VARIANT    4032   4032       G -> D (in PKD1).
FT                                {ECO:0000269|PubMed:9521593}.
FT                                /FTId=VAR_005545.
FT   VARIANT    4045   4045       I -> V (in dbSNP:rs10960).
FT                                {ECO:0000269|PubMed:10647901,
FT                                ECO:0000269|PubMed:11058904,
FT                                ECO:0000269|PubMed:11773467,
FT                                ECO:0000269|PubMed:11967008,
FT                                ECO:0000269|PubMed:12070253,
FT                                ECO:0000269|PubMed:15772804,
FT                                ECO:0000269|PubMed:18837007,
FT                                ECO:0000269|PubMed:9521593}.
FT                                /FTId=VAR_005546.
FT   VARIANT    4058   4058       V -> A. {ECO:0000269|PubMed:9150733}.
FT                                /FTId=VAR_005547.
FT   VARIANT    4059   4059       A -> V (in dbSNP:rs3209986).
FT                                {ECO:0000269|PubMed:11773467,
FT                                ECO:0000269|PubMed:11967008,
FT                                ECO:0000269|PubMed:15772804,
FT                                ECO:0000269|PubMed:18837007}.
FT                                /FTId=VAR_010095.
FT   VARIANT    4102   4102       G -> E. {ECO:0000269|PubMed:11773467}.
FT                                /FTId=VAR_058814.
FT   VARIANT    4106   4106       L -> P. {ECO:0000269|PubMed:11773467}.
FT                                /FTId=VAR_058815.
FT   VARIANT    4124   4124       P -> S. {ECO:0000269|PubMed:11967008}.
FT                                /FTId=VAR_058816.
FT   VARIANT    4132   4132       Missing (in PKD1).
FT                                {ECO:0000269|PubMed:10647901}.
FT                                /FTId=VAR_011071.
FT   VARIANT    4136   4136       R -> G (in PKD1).
FT                                {ECO:0000269|PubMed:10987650}.
FT                                /FTId=VAR_010096.
FT   VARIANT    4146   4146       V -> I (in dbSNP:rs148478410).
FT                                {ECO:0000269|PubMed:11773467,
FT                                ECO:0000269|PubMed:11967008}.
FT                                /FTId=VAR_058817.
FT   VARIANT    4150   4150       R -> C (in PKD1).
FT                                {ECO:0000269|PubMed:22508176}.
FT                                /FTId=VAR_068031.
FT   VARIANT    4154   4154       R -> C (in PKD1; dbSNP:rs115538130).
FT                                {ECO:0000269|PubMed:10987650}.
FT                                /FTId=VAR_010097.
FT   VARIANT    4155   4155       F -> V (in PKD1).
FT                                {ECO:0000269|PubMed:18837007}.
FT                                /FTId=VAR_058818.
FT   VARIANT    4190   4190       S -> F. {ECO:0000269|PubMed:11967008,
FT                                ECO:0000269|PubMed:9199561}.
FT                                /FTId=VAR_010098.
FT   VARIANT    4225   4225       Q -> P (in PKD1).
FT                                {ECO:0000269|PubMed:10200984}.
FT                                /FTId=VAR_010099.
FT   VARIANT    4255   4255       P -> S (in PKD1).
FT                                {ECO:0000269|PubMed:12220456}.
FT                                /FTId=VAR_058819.
FT   VARIANT    4276   4276       R -> W (in PKD1; dbSNP:rs114251396).
FT                                {ECO:0000269|PubMed:10200984,
FT                                ECO:0000269|PubMed:22508176}.
FT                                /FTId=VAR_010100.
FT   MUTAGEN    3049   3049       T->C,S: Does not affect auto-cleavage.
FT                                {ECO:0000269|PubMed:17525154}.
FT   MUTAGEN    3049   3049       T->G,R,V: Does not undergo auto-cleavage.
FT                                {ECO:0000269|PubMed:17525154}.
FT   CONFLICT     71     71       A -> E (in Ref. 1; AAC50128).
FT                                {ECO:0000305}.
FT   CONFLICT    138    138       R -> Q (in Ref. 1; AAC50128).
FT                                {ECO:0000305}.
FT   CONFLICT    253    253       P -> A (in Ref. 1; AAC50128).
FT                                {ECO:0000305}.
FT   CONFLICT    302    302       A -> D (in Ref. 1; AAC50128).
FT                                {ECO:0000305}.
FT   CONFLICT    691    691       P -> A (in Ref. 2; AAC37576/AAC41765).
FT                                {ECO:0000305}.
FT   CONFLICT    763    763       A -> G (in Ref. 1; AAC50128).
FT                                {ECO:0000305}.
FT   CONFLICT    774    775       AT -> QR (in Ref. 1; AAC50128).
FT                                {ECO:0000305}.
FT   CONFLICT    792    792       L -> M (in Ref. 2; AAC37576/AAC41765).
FT                                {ECO:0000305}.
FT   CONFLICT    866    866       V -> L (in Ref. 1; AAC50128).
FT                                {ECO:0000305}.
FT   CONFLICT    884    884       G -> A (in Ref. 1; AAC50128).
FT                                {ECO:0000305}.
FT   CONFLICT   1056   1056       T -> N (in Ref. 2; AAC37576/AAC41765).
FT                                {ECO:0000305}.
FT   CONFLICT   1277   1277       A -> G (in Ref. 1; AAC50128).
FT                                {ECO:0000305}.
FT   CONFLICT   1724   1724       A -> T (in Ref. 2; AAC37576/AAC41765).
FT                                {ECO:0000305}.
FT   CONFLICT   1976   1976       V -> M (in Ref. 2; AAC37576/AAC41765).
FT                                {ECO:0000305}.
FT   CONFLICT   3982   3983       QL -> HV (in Ref. 1; AAC50128).
FT                                {ECO:0000305}.
FT   CONFLICT   4005   4006       QL -> HV (in Ref. 1; AAC50128).
FT                                {ECO:0000305}.
FT   STRAND      276    278       {ECO:0000244|PDB:1B4R}.
FT   STRAND      285    296       {ECO:0000244|PDB:1B4R}.
FT   STRAND      301    306       {ECO:0000244|PDB:1B4R}.
FT   STRAND      313    317       {ECO:0000244|PDB:1B4R}.
FT   STRAND      320    325       {ECO:0000244|PDB:1B4R}.
FT   STRAND      327    338       {ECO:0000244|PDB:1B4R}.
FT   STRAND      343    353       {ECO:0000244|PDB:1B4R}.
SQ   SEQUENCE   4303 AA;  462529 MW;  AEDAC48F3F0A853C CRC64;
     MPPAAPARLA LALGLGLWLG ALAGGPGRGC GPCEPPCLCG PAPGAACRVN CSGRGLRTLG
     PALRIPADAT ALDVSHNLLR ALDVGLLANL SALAELDISN NKISTLEEGI FANLFNLSEI
     NLSGNPFECD CGLAWLPRWA EEQQVRVVQP EAATCAGPGS LAGQPLLGIP LLDSGCGEEY
     VACLPDNSSG TVAAVSFSAA HEGLLQPEAC SAFCFSTGQG LAALSEQGWC LCGAAQPSSA
     SFACLSLCSG PPPPPAPTCR GPTLLQHVFP ASPGATLVGP HGPLASGQLA AFHIAAPLPV
     TATRWDFGDG SAEVDAAGPA ASHRYVLPGR YHVTAVLALG AGSALLGTDV QVEAAPAALE
     LVCPSSVQSD ESLDLSIQNR GGSGLEAAYS IVALGEEPAR AVHPLCPSDT EIFPGNGHCY
     RLVVEKAAWL QAQEQCQAWA GAALAMVDSP AVQRFLVSRV TRSLDVWIGF STVQGVEVGP
     APQGEAFSLE SCQNWLPGEP HPATAEHCVR LGPTGWCNTD LCSAPHSYVC ELQPGGPVQD
     AENLLVGAPS GDLQGPLTPL AQQDGLSAPH EPVEVMVFPG LRLSREAFLT TAEFGTQELR
     RPAQLRLQVY RLLSTAGTPE NGSEPESRSP DNRTQLAPAC MPGGRWCPGA NICLPLDASC
     HPQACANGCT SGPGLPGAPY ALWREFLFSV PAGPPAQYSV TLHGQDVLML PGDLVGLQHD
     AGPGALLHCS PAPGHPGPRA PYLSANASSW LPHLPAQLEG TWACPACALR LLAATEQLTV
     LLGLRPNPGL RLPGRYEVRA EVGNGVSRHN LSCSFDVVSP VAGLRVIYPA PRDGRLYVPT
     NGSALVLQVD SGANATATAR WPGGSVSARF ENVCPALVAT FVPGCPWETN DTLFSVVALP
     WLSEGEHVVD VVVENSASRA NLSLRVTAEE PICGLRATPS PEARVLQGVL VRYSPVVEAG
     SDMVFRWTIN DKQSLTFQNV VFNVIYQSAA VFKLSLTASN HVSNVTVNYN VTVERMNRMQ
     GLQVSTVPAV LSPNATLALT AGVLVDSAVE VAFLWTFGDG EQALHQFQPP YNESFPVPDP
     SVAQVLVEHN VMHTYAAPGE YLLTVLASNA FENLTQQVPV SVRASLPSVA VGVSDGVLVA
     GRPVTFYPHP LPSPGGVLYT WDFGDGSPVL TQSQPAANHT YASRGTYHVR LEVNNTVSGA
     AAQADVRVFE ELRGLSVDMS LAVEQGAPVV VSAAVQTGDN ITWTFDMGDG TVLSGPEATV
     EHVYLRAQNC TVTVGAASPA GHLARSLHVL VFVLEVLRVE PAACIPTQPD ARLTAYVTGN
     PAHYLFDWTF GDGSSNTTVR GCPTVTHNFT RSGTFPLALV LSSRVNRAHY FTSICVEPEV
     GNVTLQPERQ FVQLGDEAWL VACAWPPFPY RYTWDFGTEE AAPTRARGPE VTFIYRDPGS
     YLVTVTASNN ISAANDSALV EVQEPVLVTS IKVNGSLGLE LQQPYLFSAV GRGRPASYLW
     DLGDGGWLEG PEVTHAYNST GDFTVRVAGW NEVSRSEAWL NVTVKRRVRG LVVNASRTVV
     PLNGSVSFST SLEAGSDVRY SWVLCDRCTP IPGGPTISYT FRSVGTFNII VTAENEVGSA
     QDSIFVYVLQ LIEGLQVVGG GRYFPTNHTV QLQAVVRDGT NVSYSWTAWR DRGPALAGSG
     KGFSLTVLEA GTYHVQLRAT NMLGSAWADC TMDFVEPVGW LMVAASPNPA AVNTSVTLSA
     ELAGGSGVVY TWSLEEGLSW ETSEPFTTHS FPTPGLHLVT MTAGNPLGSA NATVEVDVQV
     PVSGLSIRAS EPGGSFVAAG SSVPFWGQLA TGTNVSWCWA VPGGSSKRGP HVTMVFPDAG
     TFSIRLNASN AVSWVSATYN LTAEEPIVGL VLWASSKVVA PGQLVHFQIL LAAGSAVTFR
     LQVGGANPEV LPGPRFSHSF PRVGDHVVSV RGKNHVSWAQ AQVRIVVLEA VSGLQVPNCC
     EPGIATGTER NFTARVQRGS RVAYAWYFSL QKVQGDSLVI LSGRDVTYTP VAAGLLEIQV
     RAFNALGSEN RTLVLEVQDA VQYVALQSGP CFTNRSAQFE AATSPSPRRV AYHWDFGDGS
     PGQDTDEPRA EHSYLRPGDY RVQVNASNLV SFFVAQATVT VQVLACREPE VDVVLPLQVL
     MRRSQRNYLE AHVDLRDCVT YQTEYRWEVY RTASCQRPGR PARVALPGVD VSRPRLVLPR
     LALPVGHYCF VFVVSFGDTP LTQSIQANVT VAPERLVPII EGGSYRVWSD TRDLVLDGSE
     SYDPNLEDGD QTPLSFHWAC VASTQREAGG CALNFGPRGS STVTIPRERL AAGVEYTFSL
     TVWKAGRKEE ATNQTVLIRS GRVPIVSLEC VSCKAQAVYE VSRSSYVYLE GRCLNCSSGS
     KRGRWAARTF SNKTLVLDET TTSTGSAGMR LVLRRGVLRD GEGYTFTLTV LGRSGEEEGC
     ASIRLSPNRP PLGGSCRLFP LGAVHALTTK VHFECTGWHD AEDAGAPLVY ALLLRRCRQG
     HCEEFCVYKG SLSSYGAVLP PGFRPHFEVG LAVVVQDQLG AAVVALNRSL AITLPEPNGS
     ATGLTVWLHG LTASVLPGLL RQADPQHVIE YSLALVTVLN EYERALDVAA EPKHERQHRA
     QIRKNITETL VSLRVHTVDD IQQIAAALAQ CMGPSRELVC RSCLKQTLHK LEAMMLILQA
     ETTAGTVTPT AIGDSILNIT GDLIHLASSD VRAPQPSELG AESPSRMVAS QAYNLTSALM
     RILMRSRVLN EEPLTLAGEE IVAQGKRSDP RSLLCYGGAP GPGCHFSIPE AFSGALANLS
     DVVQLIFLVD SNPFPFGYIS NYTVSTKVAS MAFQTQAGAQ IPIERLASER AITVKVPNNS
     DWAARGHRSS ANSANSVVVQ PQASVGAVVT LDSSNPAAGL HLQLNYTLLD GHYLSEEPEP
     YLAVYLHSEP RPNEHNCSAS RRIRPESLQG ADHRPYTFFI SPGSRDPAGS YHLNLSSHFR
     WSALQVSVGL YTSLCQYFSE EDMVWRTEGL LPLEETSPRQ AVCLTRHLTA FGASLFVPPS
     HVRFVFPEPT ADVNYIVMLT CAVCLVTYMV MAAILHKLDQ LDASRGRAIP FCGQRGRFKY
     EILVKTGWGR GSGTTAHVGI MLYGVDSRSG HRHLDGDRAF HRNSLDIFRI ATPHSLGSVW
     KIRVWHDNKG LSPAWFLQHV IVRDLQTARS AFFLVNDWLS VETEANGGLV EKEVLAASDA
     ALLRFRRLLV AELQRGFFDK HIWLSIWDRP PRSRFTRIQR ATCCVLLICL FLGANAVWYG
     AVGDSAYSTG HVSRLSPLSV DTVAVGLVSS VVVYPVYLAI LFLFRMSRSK VAGSPSPTPA
     GQQVLDIDSC LDSSVLDSSF LTFSGLHAEQ AFVGQMKSDL FLDDSKSLVC WPSGEGTLSW
     PDLLSDPSIV GSNLRQLARG QAGHGLGPEE DGFSLASPYS PAKSFSASDE DLIQQVLAEG
     VSSPAPTQDT HMETDLLSSL SSTPGEKTET LALQRLGELG PPSPGLNWEQ PQAARLSRTG
     LVEGLRKRLL PAWCASLAHG LSLLLVAVAV AVSGWVGASF PPGVSVAWLL SSSASFLASF
     LGWEPLKVLL EALYFSLVAK RLHPDEDDTL VESPAVTPVS ARVPRVRPPH GFALFLAKEE
     ARKVKRLHGM LRSLLVYMLF LLVTLLASYG DASCHGHAYR LQSAIKQELH SRAFLAITRS
     EELWPWMAHV LLPYVHGNQS SPELGPPRLR QVRLQEALYP DPPGPRVHTC SAAGGFSTSD
     YDVGWESPHN GSGTWAYSAP DLLGAWSWGS CAVYDSGGYV QELGLSLEES RDRLRFLQLH
     NWLDNRSRAV FLELTRYSPA VGLHAAVTLR LEFPAAGRAL AALSVRPFAL RRLSAGLSLP
     LLTSVCLLLF AVHFAVAEAR TWHREGRWRV LRLGAWARWL LVALTAATAL VRLAQLGAAD
     RQWTRFVRGR PRRFTSFDQV AQLSSAARGL AASLLFLLLV KAAQQLRFVR QWSVFGKTLC
     RALPELLGVT LGLVVLGVAY AQLAILLVSS CVDSLWSVAQ ALLVLCPGTG LSTLCPAESW
     HLSPLLCVGL WALRLWGALR LGAVILRWRY HALRGELYRP AWEPQDYEMV ELFLRRLRLW
     MGLSKVKEFR HKVRFEGMEP LPSRSSRGSK VSPDVPPPSA GSDASHPSTS SSQLDGLSVS
     LGRLGTRCEP EPSRLQAVFE ALLTQFDRLN QATEDVYQLE QQLHSLQGRR SSRAPAGSSR
     GPSPGLRPAL PSRLARASRG VDLATGPSRT PLRAKNKVHP SST
//
